6,156 Shares in McKesson Co. (NYSE:MCK) Purchased by Quantessence Capital LLC

Quantessence Capital LLC bought a new stake in McKesson Co. (NYSE:MCK - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 6,156 shares of the company's stock, valued at approximately $3,508,000. McKesson comprises approximately 1.4% of Quantessence Capital LLC's investment portfolio, making the stock its 17th largest position.

A number of other large investors also recently made changes to their positions in the company. Geode Capital Management LLC raised its stake in shares of McKesson by 0.4% during the 4th quarter. Geode Capital Management LLC now owns 2,663,303 shares of the company's stock worth $1,513,195,000 after purchasing an additional 10,015 shares during the period. Franklin Resources Inc. increased its holdings in McKesson by 4.6% during the fourth quarter. Franklin Resources Inc. now owns 2,620,948 shares of the company's stock worth $1,493,704,000 after buying an additional 114,396 shares during the last quarter. Norges Bank bought a new stake in McKesson in the fourth quarter worth about $1,200,361,000. Boston Partners boosted its stake in McKesson by 24.6% in the fourth quarter. Boston Partners now owns 1,096,301 shares of the company's stock valued at $625,501,000 after acquiring an additional 216,432 shares during the last quarter. Finally, Nordea Investment Management AB increased its stake in shares of McKesson by 20.0% during the 4th quarter. Nordea Investment Management AB now owns 975,935 shares of the company's stock worth $558,606,000 after purchasing an additional 162,688 shares during the last quarter. 85.07% of the stock is owned by institutional investors.

Insider Transactions at McKesson

In other McKesson news, CEO Brian S. Tyler sold 8,961 shares of McKesson stock in a transaction that occurred on Friday, February 21st. The stock was sold at an average price of $597.99, for a total value of $5,358,588.39. Following the transaction, the chief executive officer now directly owns 60,664 shares of the company's stock, valued at $36,276,465.36. The trade was a 12.87 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Leann B. Smith sold 188 shares of the stock in a transaction that occurred on Wednesday, February 12th. The shares were sold at an average price of $609.59, for a total value of $114,602.92. Following the sale, the executive vice president now directly owns 1,051 shares of the company's stock, valued at approximately $640,679.09. This trade represents a 15.17 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 18,110 shares of company stock worth $10,855,706. 0.11% of the stock is currently owned by insiders.

McKesson Trading Up 0.9 %

Shares of McKesson stock traded up $6.19 on Friday, hitting $694.62. 731,510 shares of the company traded hands, compared to its average volume of 892,117. McKesson Co. has a 12-month low of $464.42 and a 12-month high of $728.32. The company has a market cap of $87.05 billion, a P/E ratio of 31.80, a P/E/G ratio of 1.29 and a beta of 0.49. The firm's 50-day simple moving average is $659.36 and its 200 day simple moving average is $605.06.

McKesson (NYSE:MCK - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing analysts' consensus estimates of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. Analysts predict that McKesson Co. will post 32.77 earnings per share for the current year.

McKesson Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, April 1st. Shareholders of record on Monday, March 3rd were paid a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a dividend yield of 0.41%. The ex-dividend date of this dividend was Monday, March 3rd. McKesson's dividend payout ratio (DPR) is presently 13.00%.

Wall Street Analyst Weigh In

MCK has been the topic of several research reports. Evercore ISI boosted their target price on McKesson from $650.00 to $675.00 and gave the company an "outperform" rating in a research note on Thursday, February 6th. Morgan Stanley increased their target price on shares of McKesson from $642.00 to $745.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 2nd. Citigroup cut their price objective on shares of McKesson from $713.00 to $677.00 and set a "buy" rating for the company in a report on Friday, January 10th. Wells Fargo & Company increased their target price on McKesson from $641.00 to $691.00 and gave the stock an "equal weight" rating in a research report on Friday, March 14th. Finally, StockNews.com cut McKesson from a "strong-buy" rating to a "buy" rating in a report on Friday, February 14th. Three investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, McKesson has a consensus rating of "Moderate Buy" and a consensus price target of $668.50.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.